📈 ASX: australian-clinical-labs-limited
Daily Digest – 02 Oct (ASX:australian-clinical-labs-limited)
Published 1 October 2025Daily Digest
Australian Clinical Labs Limited
ASX: ACL
ACL’s FY25 growth was driven by core testing rebound and high-margin specialist diagnostics.
(Source: TradingView) 3-Month Performance Profile of ACL on a DTF compared to S&P/ASX 200 (XJO).
Australian Clinical Labs closed FY25 with a solid operational uplift, reflecting both recovery in core testing and momentum in higher-value services. Medicare-
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Daily Digest
A$200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Daily Digest
Stay informed with expert daily ASX research covering four carefully selected stocks, complete with market insights, risk ratings, and clear Buy, Hold, or Sell general guidance—delivered before the market opens each trading day.
- ✓ Four Expert-Selected ASX Stocks Daily
- ✓ Weekday Pre-Market Delivery
- ✓ In-Depth Research & Analysis
- ✓ Access to All Previous Reports
A$200.00/ 12 months
Risk:Medium
Subscribe Now →
